FOR IMMEDIATE RELEASE

May 13, 2010 (Irvine, California) - BioMedGPS, a provider of online business intelligence for life science executives and organizer of the JointVentures Strategic Partnering and Investment conference, reports that the US market for Cartilage Repair and Replacement technologies will reach $44.5 million in 2010 and grow at a rate of 6.8% to $57.9 million in 2014. According to the SmartTRAK OrthoBio database, more than 10 cartilage replacement technologies may be on the US market by 2014, fueling growth in this arena in the latter half of the decade. This and other market data is published in BioMedGPS’ newly released SmartTRAK OrthoBio: Cartilage database.

SmartTRAK Online Business Intelligence is an innovative electronic platform that provides real-time business intelligence and analysis on medical device markets, companies and products, that is updated daily as events in the industry occur. The SmartTRAK OrthoBio: Cartilage module profiles over 50 US and OUS companies, including 32 privately held firms, and close to 70 products, on the market or under development, composed of cell-based, growth factor, stem cell, synthetics, composites and allograft technologies. Also included in the SmartTRAK OrthoBio: Cartilage database is a Market Profile that includes 5-year sales and procedure volumes forecasts, competitive market shares, and regulatory and reimbursement information.

“Cartilage replacement represents an enormous untapped opportunity, since many of the current treatments are palliative in nature and a cartilage injury often initiates the cascade of events that leads to degenerative joint disease,” reports Sharon O’Reilly, Founder, President and CEO of BioMedGPS, the developer of the SmartTRAK Online Business Intelligence system. “Many of the emerging companies developing technologies including stem cells, growth factors and synthetic joint resurfacing are profiled in the SmartTRAK OrthoBio: Cartilage database—making it easy for life science executives to quickly identify where the opportunities for investment and strategic alliance are. Already, three acquisitions have occurred in the cartilage replacement arena in the last year and there are likely more to come,” states O’Reilly.

Designed to replace print market and technology reports widely used in the industry today, SmartTRAK Online Business Intelligence will transform the delivery of medical device business information from static data to real time information and analysis. SmartTRAK tracks emerging companies, competitive developments, regulatory approvals, and strategic alliances and presents this information in individual market, company and product profiles that are updated daily to provide users with a current "snapshot" of a medical device industry segment. SmartTRAK allows users to search, sort, store and share information—increasing the productivity of executives and saving companies money.

Contact BioMedGPS to schedule a live demo with your team.

About BioMedGPS, LLC
Founded by Sharon O'Reilly, Founder and former CEO of Medtech Insight, BioMedGPS provides online business intelligence and dynamic decision-making tools specifically designed for life science executives. In addition to SmartTRAK, the Company also holds focused Strategic Partnering and Investment Conferences, and provides medical device market expertise via its Consulting Group.

CONTACT:
Sharon O’Reilly or Tracy Neilssien
949-559-5511
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.biomedgps.com